News | December 19, 2025
Lupin signs exclusive licensing pact with Neopharmed for Plasil in Philippines and Brazil
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
The new facility is expected to generate 500-600 new jobs in the region
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
Future of manufacturing lies in mobility based manufacturing
Subscribe To Our Newsletter & Stay Updated
